170 SinghG.KapoorI
This is especially relevant in obesogenic environments such as modern diets, rich in ultra-processed and high-caloric foods, which have contributed to nearly 45% of the global adult population living with overweight or obesity (1214)
Note changes in appetite or blood sugar levels (if applicable)
Liraglutide therapy exhibited good safety tolerability, with gastrointestinal symptoms representing the predominant adverse events: nausea affected 46% of liraglutide users vs
The program offers a wide range of options, including brand-name GLP-1s like Wegovy, Zepbound, Ozempic, and Rybelsus, along with compounded semaglutide in injectable and oral forms
Its abundance has been associated with several markers of metabolic and gut health, although association does not prove that supplementation will correct every metabolic condition